Piper Sandler Maintains Overweight on CVS Health, Lowers Price Target to $99

Benzinga Newsdesk www.benzinga.com Negative 63.7%

Neg 63.7% Neu 0% Pos 0%

Piper Sandler analyst Jessica Tassan maintains CVS Health (NYSE:CVS) with a Overweight and lowers the price target from $101 to $99.